BIIB-094 is an antisense therapeutic designed to reduce LRRK2 levels through LRRK2 reduction. Antisense therapies work by interfering with the production of specific proteins at the genetic level, thus lowering the amount of LRRK2 protein, which is believed to contribute to Parkinson’s disease progression.
Discover our Products
Science-based supplements that work synergistically
Sign Up to our Newsletter to get notified when the YuthLabs Red and Infrared Light Cap is live!
Subscribe & Join Our Pre-Order Waitlist
